Abstract
Objectives: To determine the frequency of Intracerebral Haemorrhage (ICH) in
patients taking antiplatelet therapy. Study Design: Cross-Sectional Study. Setting: Emergency
Department at Ziauddin Hospital. Period: 2014-2016. Material & Methods: A total number of
75 patients with ICH, diagnosed by C.T Scan Brain Plain were included in this study. After the
diagnosis of ICH on C.T scan Brain, patients were selected as with prior use of antiplatelets or
secondary to other causes. Brief history was taken from the patients and attendants regarding
the history of antiplatelets use. Results: The average ages of the patients were 59.97±12.46
years. There were 57.33% male and 42.67% female. Out of 75 ICH patients 44% (33/75) were
taking antiplatelet therapy. Median duration of APT was 12[IQR=24] months. Out of these 33
patients 78.8% (26/33) were taking single APT and 21.2% (7/33) were taking dual APT. Mean
age was significantly high in patients those who are on antiplatelet therapy as compare to those
who was not on APT (p=0.033). Gender and systematic finding of patients were not significant
those who are not on APT and on APT. Comorbid like DM, HTN and IHD were significant high
in patients on APT and in hospital mortality was also not significant in patients on APT and not
on APT. Conclusion: In this study overall in hospital mortality was observed in 13.33%. These
study suggests there is only modestly increased mortality in patients taking pre-ICH APT, and
little or no increase in poor functional outcomes there are a substantial number of ICH patients
taking pre-ICH APT who could be at risk. For the reduction in morbidity related to APT-ICH
Prevention of risk factor like HTN is most antonyms strategy
Lal Shehbaz, Shua Nasir , Abdul Naveed Khan. (2020) To determine the frequency of intracerebral haemorrhage (ICH) in patients taking antiplatelet therapy., The Professional Medical Journal, Volume 27, Issue 12.
-
Views
673 -
Downloads
89
